APA (7th ed.) Citation

J, P., V, G., I, C., J, L., M, A., A, M., . . . E, G. (2024). Preclinical data and design of a phase I clinical trial of neoantigen-reactive TILs for advanced epithelial or ICB-resistant solid cancers. Immuno-oncology technology, 25, 101030. https://doi.org/10.1016/j.iotech.2024.101030

Chicago Style (17th ed.) Citation

J, Palomero, et al. "Preclinical Data and Design of a Phase I Clinical Trial of Neoantigen-reactive TILs for Advanced Epithelial or ICB-resistant Solid Cancers." Immuno-oncology Technology 25 (2024): 101030. https://doi.org/10.1016/j.iotech.2024.101030.

MLA (9th ed.) Citation

J, Palomero, et al. "Preclinical Data and Design of a Phase I Clinical Trial of Neoantigen-reactive TILs for Advanced Epithelial or ICB-resistant Solid Cancers." Immuno-oncology Technology, vol. 25, 2024, p. 101030, https://doi.org/10.1016/j.iotech.2024.101030.